BarnesTRMutsatsaSHHuttonSBWattHCJoyceEM (2006) Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry188: 237–242.
2.
ColdhamELAddingtonJAddingtonD (2002) Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand106: 286–290.
3.
FranzLCarterTLeinerASBergnerEThompsonNJComptonMT (2010) Stigma and treatment delay in first-episode psychosis: a grounded theory study. Early Interv Psychiatry4: 47–56.
4.
GaryFA (2005) Stigma: barrier to mental health care among ethnic minorities. Issues Ment Health Nurs26: 979–999.
5.
HaddadPMSharmaSG (2007) Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs21: 911–936.
6.
HaddadPMDasAKeyhaniSChaudhryIB (2011) Antipsychotic drugs and extrapyramidal side-effects in first episode psychosis: a systematic review of head-head comparisons. J Psychopharmacol26: 15–26.
7.
JoaIJohannessenJOAuestadBFriisSMcGlashanTMelleI. (2008) The key to reducing duration of untreated first psychosis: information campaigns. Schizophr Bull34: 466–472.
8.
McGorryPDYungARPhillipsLJ (2002) Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry59: 921–928.
9.
MarshallMLewisSLockwoodADrakeRJonesPCroudaceT (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry62: 975–983.
10.
MorrisonAPFrenchPWalfordL (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry185: 291–297.
11.
RobinsonDWoernerMGAlvirJMBilderRGoldmanRGeislerS. (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry56: 241–247.
12.
SempleDMMcIntoshAMLawrieSM (2005) Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol19: 187–194.
13.
ThomasSPNandhraHS (2009) Early intervention in psychosis: a retrospective analysis of clinical and social factors influencing duration of untreated psychosis. Prim Care Companion J Clin Psychiatry11: 212–214.
14.
ThornicroftGBrohanERoseDSartoriusNLeeseM, INDIGO Study Group (2009) Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet373: 408–415.
15.
TurkingtonAMulhollandCCRusheTMAndersonRMcCaulRBarrettSL. (2009) Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry195: 242–248.
